Thomas Bogenrieder

Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression

Christos N. Papandreou, B A Usmani, Yiping Geng et al. · Nature Medicine · 1998 · 279 citations

Urology, Pathology, Androgen-independent Progression +6

Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

Lucy Ireland, Almudena Santos, Muhammad S. Ahmed et al. · Cancer Research · 2016 · 241 citations · Full text

Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8

Helmut Schaider, Masahiro Oka, Thomas Bogenrieder et al. · International Journal of Cancer · 2002 · 173 citations · Full text

Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

Jalid Sehouli, Dirk Stengel, Philipp Harter et al. · Journal of Clinical Oncology · 2010 · 103 citations · Full text

Reciprocal regulation of MelCAM and AKT in human melanoma

Gang Li, Jiří Kalabis, Xiaowei Xu et al. · Oncogene · 2003 · 89 citations

Reciprocal Regulation, Photocarcinogenesis, Melanoma +5